Inspire Corporate Bond ETF (IBD)
| Assets | $472.41M |
| Expense Ratio | 0.41% |
| PE Ratio | n/a |
| Shares Out | 19.70M |
| Dividend (ttm) | $1.01 |
| Dividend Yield | 4.25% |
| Ex-Dividend Date | Apr 24, 2026 |
| Payout Frequency | Monthly |
| Payout Ratio | n/a |
| Volume | 131,315 |
| Open | 23.84 |
| Previous Close | 23.90 |
| Day's Range | 23.82 - 23.94 |
| 52-Week Low | 23.48 |
| 52-Week High | 24.85 |
| Beta | 0.21 |
| Holdings | 251 |
| Inception Date | Jul 10, 2017 |
About IBD
Fund Home PageThe Inspire Corporate Bond ETF (IBD) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks an equally weighted index of bonds issued by S&P 500-component companies that meet biblically responsible investing standards according to the Issuer. IBD was launched on Jul 10, 2017 and is issued by Inspire.
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Apr 24, 2026 | $0.0788 | Apr 29, 2026 |
| Mar 27, 2026 | $0.0932 | Apr 1, 2026 |
| Feb 24, 2026 | $0.0779 | Mar 2, 2026 |
| Jan 27, 2026 | $0.0592 | Feb 2, 2026 |
| Dec 17, 2025 | $0.121 | Dec 24, 2025 |
| Nov 21, 2025 | $0.0729 | Nov 26, 2025 |
Performance
IBD had a total return of 5.77% in the past year, including dividends. Since the fund's inception, the average annual return has been 2.18%.
News
Scripps Research Advances Breakthrough Regenerative Medicines to Reverse Aging-Related Diseases
LA JOLLA, Calif.--(BUSINESS WIRE)--As people live longer than ever before, the incidence of aging-related, chronic diseases is on the rise, severely impacting quality of life and placing an unpreceden...
Inspire ETFs Reports Expense Ratio Reductions for 7 Funds
Inspire Investing has announced fee reductions on seven of its biblically responsible, faith-based ESG ETFs BOISE, Idaho , May 2, 2022 /PRNewswire/ -- Inspire Investing, the world's largest provider o...